Industry experts discuss the agency’s plans to make the drug approval process more transparent.
The Scientist
Most Recent
An Amgen executive refutes accusations that the company published misleading results of its mid-90s clinical trial testing an anemia drug.
Researchers pull viable cells from bodies that had been dead for more than 2 weeks.
New research finds that older men have children and grandchildren with longer telomeres, possibly pointing to health benefits of delayed reproduction.
The regulatory agency will allow early-stage breast cancer patients to try experimental drugs previously reserved for those with advanced disease.
Whether working for a pharmaceutical giant or a biotech start-up with a unique vision, researchers who responded to this year’s Best Places to Work in Industry survey are translating society’s most pressing scientific needs into a new generation of d
Contributors
June 1, 2012
Meet some of the people featured in the June 2012 issue of The Scientist.
Gene therapies typically involve the introduction of genetic material into target cells to replace or supplement an existing, usually dysfunctional, gene. Techniques for delivering the corrective payload vary widely. Many gene therapies utilize modif
Actin filaments respond to pressure by forming branches at their curviest spots, helping resist the push.
EDITOR'S CHOICE IN MICROBIOLOGY The paper S. Alsford et al., “High-throughput decoding of antitrypanosomal drug efficacy and resistance,” Nature, 482:232-36, 2012. The finding Trypanosoma brucei, the single-cell protozoan that causes the tropical
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
